Clopidogrel Versus Aspirin For The Treatment Of Acute Coronary Syndrome After A 12-Month Dual Antiplatelet Therapy- A Cost-Effectiveness Analysis From China Payer’s Perspective
Abstract
Authors
L Zhang Z Lin H Yin J Liu J Xuan
L Zhang Z Lin H Yin J Liu J Xuan
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now